Health Canada drug identification number

DIN 02528398 — CIBINQO 200 MG

CIBINQO is a tablet of Abrocitinib marketed by PFIZER CANADA ULC. The full Abrocitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02528398
Brand name
CIBINQO
Active ingredient
Abrocitinib
Strength
200 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Janus kinase 1 (JAK1) inhibitor

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Abrocitinib products

DINBrandStrengthFormManufacturerStatus
02528371 CIBINQO 100 MG TABLET PFIZER CANADA ULC MARKETED
02528363 CIBINQO 50 MG TABLET PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.